Not a good buy right now for an impatient investor: momentum is still bearish (MACD worsening) and price is weak below the key pivot (6.837).
Oversold RSI (11.88) can trigger a short bounce, but without a proprietary buy signal and with downside-biased pattern stats, the risk is that weakness continues toward 5.63 support.
Positioning/Sentiment: Put/Call OI ratio 0.24 indicates more call OI than put OI (bullish tilt), but today’s options volume is 0 (very low/illiquid signal quality).
Volatility: 30D IV 112.29 vs historical vol 47.65 and IV percentile 96.81 = options are pricing very large moves; this often coincides with uncertainty ahead of an event window.
Takeaway: bullish OI skew, but lack of volume and extremely elevated IV make sentiment harder to trust and option buying expensive.
Technical Summary
Sell
9
Buy
5
Positive Catalysts
citing strategic moves/partnerships and synergy/efficiency-driven EBITDA upside.
Neutral/Negative Catalysts
while volume is absent—adds “event risk” without clear directional confirmation.
2025-12-02: Evercore ISI raised PT to $12 from $10; rating Outperform.
2025-11-11: Morgan Stanley raised PT to $8 from $7; rating Equal Weight.
Wall Street pros: synergy/efficiency upside (notably tied to acquisitions) and improving longer-term EBITDA trajectory; stock seen as under-followed.
Wall Street cons: despite higher PTs, at least one major firm stays neutral (Equal Weight), and the current financial profile still shows widening losses—limiting near-term conviction.
Wall Street analysts forecast GBTG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GBTG is 10.25 USD with a low forecast of 8 USD and a high forecast of 12 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast GBTG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GBTG is 10.25 USD with a low forecast of 8 USD and a high forecast of 12 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 5.630
Low
8
Averages
10.25
High
12
Current: 5.630
Low
8
Averages
10.25
High
12
Evercore ISI
Outperform
maintain
$10 -> $12
AI Analysis
2025-12-02
Reason
Evercore ISI
Price Target
$10 -> $12
AI Analysis
2025-12-02
maintain
Outperform
Reason
Evercore ISI raised the firm's price target on Global Business Travel to $12 from $10 and keeps an Outperform rating on the shares. GBTG's strategic moves and partnerships are "positioning it well for future growth," but the stock is "still flying under the radar" despite a "notable" increase in adjusted EBITDA projections for 2027, driven by acquisition synergies and operational efficiencies, the analyst tells investors.
Morgan Stanley
Equal Weight
maintain
$7 -> $8
2025-11-11
Reason
Morgan Stanley
Price Target
$7 -> $8
2025-11-11
maintain
Equal Weight
Reason
Morgan Stanley raised the firm's price target on Global Business Travel to $8 from $7 and keeps an Equal Weight rating on the shares. Following the Q3 report, the firm increased its FY25 and FY26 adjusted EBITDA estimates by 3% and 14%, respectively, to reflect the CWT acquisition, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for GBTG